by Jackie (née Heneghan) Peck | Jun 1, 2018 | Analyisis, Behind the scenes, Blog, Brexit, Business, GDP/RP
Changes to the way data is held and processed are now in place since the adoption of GDPR legislation which came into force on the 25th May. Unless you have been living on a desert island somewhere, you could hardly have failed to notice this given the plethora of...
by Jackie (née Heneghan) Peck | Jul 19, 2015 | Analyisis, Behind the scenes, Blog, Falsified Medicines, Good Distribution Practice - GDP, MHRA, Pharmacy Suppliers, Regulation, RP, WDA(H), WDA(H)
In May, the FDA in conjunction with international law enforcements agencies enforced a major crackdown on illegal and crackdown medications with action taken against 1,050 websites. Seized products were found to have originated in India, China, Hong Kong and...
by Jackie (née Heneghan) Peck | Jul 19, 2015 | Analyisis, Blog, Business, Community Pharmacy, Regulation
The Therapeutic Goods Administration (TGA) are aiming to remove unnecessary duplication in assessing therapeutic goods in Australia where they have been approved elsewhere in the world. New assessment protocols will allow changes to streamline the process and use...
by Jackie (née Heneghan) Peck | Jul 19, 2015 | Analyisis, Blog, Business, Community Pharmacy, Pharmacist, Pharmacy Brands
News made it here to Australia over the 700 job cuts imposed within the Boots head office and support network noting that the job cuts will not be coming from within any retail locations. This news follows the Boots merger with US chain Walgreens and whilst not...
by Jackie (née Heneghan) Peck | Jul 19, 2015 | Analyisis, Blog, Business, Community Pharmacy, GPhC, Pharmacist, Regulation
The community pharmacy industry remains heavily regulated in Australia as most of us in the industry believe it should be. In every case, rules are there for a reason and though we know the rules sometimes some of us simply ignore them. Here in Australia, the...
by Ryan Watts | Jul 1, 2015 | Analyisis, Behind the scenes, Blog, Business, Distance Selling Pharmacy, EudraGMDP, External Audit, Good Distribution Practice - GDP, GPhC, MHRA, Pharmacy Suppliers, Quality Systems, Regulation, SOPs, Transportation
In a recent case a supplier of biologically active products for clinical trials was reported to the HSE for not supplying Safety Data Sheets (SDS) to their client. Under the CHIP or Chemicals (Hazard Information and Packaging for Supply) Regulations 2002, suppliers...
